Domain

Details

pharmusa.biz appears in our database 303 times

  • Details

  • Abuse History

  • Whois

Date IP Address Username Email Location Evidence
16-Aug-19 04:20
93.179.90.17
rvdtea
 
nsrkoc@pharmusa.biz
Czech Republic Evidence
12-Aug-19 17:30
91.222.236.105
gqhgcu
 
oeucuf@pharmusa.biz
Russian Federation Evidence
11-Aug-19 20:15
95.181.177.82
gkvbgn
 
zcioxf@pharmusa.biz
Poland Evidence
10-Aug-19 23:22
79.110.28.50
zpucqr
 
ckuyog@pharmusa.biz
United Kingdom  
10-Aug-19 06:55
188.68.0.20
vpnpgv
 
klhjbs@pharmusa.biz
United Kingdom Evidence
8-Aug-19 00:38
95.85.80.198
qgiqri
 
nirgio@pharmusa.biz
United Kingdom Evidence
7-Aug-19 19:10
188.68.3.75
zkegdy
 
fydyrh@pharmusa.biz
Czech Republic Evidence
6-Aug-19 22:40
95.85.80.220
krwvzb
 
gqxfgu@pharmusa.biz
United Kingdom Evidence
5-Aug-19 23:50
185.251.71.114
ewtspp
 
uiulha@pharmusa.biz
  Evidence
28-Jul-19 16:51
185.251.15.230
xqhdtp
 
diqtyh@pharmusa.biz
   
26-Jul-19 09:50
84.54.58.88
mnsobv
 
pkyoqn@pharmusa.biz
  Evidence
26-Jul-19 09:35
95.181.176.240
duqbkj
 
rdfkyz@pharmusa.biz
Latvia Evidence
26-Jul-19 09:30
46.161.61.194
lnmlyb
 
aurriq@pharmusa.biz
Belgium Evidence
26-Jul-19 09:15
46.161.61.139
dptvls
 
lvtmxa@pharmusa.biz
Belgium Evidence
26-Jul-19 09:00
193.93.195.168
yqavio
 
okyqqq@pharmusa.biz
Russian Federation Evidence
26-Jul-19 08:45
5.101.220.129
qrfvrb
 
bfnibk@pharmusa.biz
Latvia Evidence
26-Jul-19 08:20
95.85.69.174
jcsfgm
 
uxofpg@pharmusa.biz
Russian Federation Evidence
26-Jul-19 08:20
85.202.194.225
wnhbgc
 
inoizi@pharmusa.biz
  Evidence
26-Jul-19 08:00
176.119.141.208
vrvjtd
 
wkaruj@pharmusa.biz
  Evidence
26-Jul-19 07:35
95.181.177.178
zwicwy
 
wkjqbl@pharmusa.biz
Poland Evidence
26-Jul-19 07:30
188.68.0.201
xfrcvx
 
vlvasf@pharmusa.biz
United Kingdom Evidence
26-Jul-19 07:25
95.181.177.249
hxzqxy
 
vcakqz@pharmusa.biz
Poland Evidence
26-Jul-19 07:25
193.32.95.253
ykkobv
 
wekuho@pharmusa.biz
  Evidence
26-Jul-19 07:20
185.251.14.165
ujecwp
 
hawgnm@pharmusa.biz
  Evidence
26-Jul-19 07:10
95.85.71.210
xkevtd
 
xduzuq@pharmusa.biz
Russian Federation Evidence
26-Jul-19 07:05
188.68.0.16
rmvdav
 
aulpjw@pharmusa.biz
United Kingdom Evidence
26-Jul-19 07:05
94.158.22.20
nqueef
 
emaqoe@pharmusa.biz
  Evidence
26-Jul-19 05:45
91.204.14.248
iunshp
 
pblmqg@pharmusa.biz
Germany Evidence
26-Jul-19 05:10
185.251.15.25
wikkvo
 
atzbri@pharmusa.biz
  Evidence
26-Jul-19 01:22
37.44.252.201
akimrn
 
hzpodl@pharmusa.biz
Russian Federation  
26-Jul-19 01:15
185.46.84.189
ddbury
 
lntbzr@pharmusa.biz
Poland Evidence
26-Jul-19 00:35
193.93.192.22
ptimgi
 
pidyiq@pharmusa.biz
United Kingdom Evidence
26-Jul-19 00:10
185.251.14.229
xdeyik
 
kaebod@pharmusa.biz
  Evidence
25-Jul-19 23:15
185.223.161.82
fppfwn
 
fotcan@pharmusa.biz
  Evidence
25-Jul-19 22:45
84.54.58.234
zepiwn
 
yvlosb@pharmusa.biz
  Evidence
25-Jul-19 21:35
194.156.124.123
gbqqml
 
bcxqso@pharmusa.biz
  Evidence
25-Jul-19 21:25
95.181.177.91
mholtp
 
meagvh@pharmusa.biz
Poland Evidence
25-Jul-19 20:34
185.251.71.151
hiooir
 
ncpjgx@pharmusa.biz
   
25-Jul-19 19:25
5.189.205.172
jzzrar
 
gpizgk@pharmusa.biz
France Evidence
25-Jul-19 19:15
83.171.252.29
xwzzhd
 
dhpebz@pharmusa.biz
  Evidence
25-Jul-19 18:25
95.85.70.225
otedyk
 
hnsfae@pharmusa.biz
Russian Federation Evidence
25-Jul-19 16:00
185.251.71.160
pbbbcn
 
mozmbq@pharmusa.biz
  Evidence
25-Jul-19 12:00
95.181.176.208
cnnvxd
 
ndgjyk@pharmusa.biz
Latvia Evidence
25-Jul-19 11:20
91.222.239.14
yhgtnb
 
ljbwcn@pharmusa.biz
Russian Federation Evidence
25-Jul-19 10:35
85.202.194.118
iuykim
 
fqnfrz@pharmusa.biz
  Evidence
25-Jul-19 09:20
85.202.195.206
mfddqi
 
lmexbe@pharmusa.biz
  Evidence
25-Jul-19 09:15
185.251.70.252
eyjcqt
 
tyhnkc@pharmusa.biz
  Evidence
25-Jul-19 09:00
2.57.77.236
txjihz
 
ssczmq@pharmusa.biz
  Evidence
25-Jul-19 08:40
188.68.3.133
cqcnfz
 
cgluik@pharmusa.biz
Czech Republic Evidence
25-Jul-19 08:40
188.68.3.236
xguvhh
 
piswqx@pharmusa.biz
Czech Republic Evidence
25-Jul-19 07:45
185.251.71.128
biijnx
 
uzxgix@pharmusa.biz
  Evidence
25-Jul-19 07:30
91.222.236.199
zfxojz
 
qtidxv@pharmusa.biz
Russian Federation Evidence
25-Jul-19 06:45
185.251.15.140
iwuaan
 
kcrwqo@pharmusa.biz
  Evidence
25-Jul-19 06:20
93.179.90.27
pxeswb
 
kdnfqh@pharmusa.biz
Czech Republic Evidence
25-Jul-19 06:15
185.251.70.203
yfxcmz
 
tjppkp@pharmusa.biz
  Evidence
25-Jul-19 03:15
193.93.192.147
uyosts
 
rpelys@pharmusa.biz
United Kingdom Evidence
25-Jul-19 02:35
94.158.22.165
lunplt
 
svevde@pharmusa.biz
  Evidence
25-Jul-19 00:40
5.101.220.198
expdki
 
dhhogl@pharmusa.biz
Latvia Evidence
24-Jul-19 23:25
91.222.236.103
frknkg
 
jcunbu@pharmusa.biz
Russian Federation Evidence
24-Jul-19 22:35
212.115.51.24
meadsg
 
vtfwqj@pharmusa.biz
  Evidence
24-Jul-19 22:35
95.85.70.241
ovinni
 
wbesbe@pharmusa.biz
Russian Federation Evidence
24-Jul-19 22:30
185.14.194.68
kupsvi
 
tclfsq@pharmusa.biz
United Kingdom  
24-Jul-19 20:15
95.85.80.167
grfsxt
 
kkgubb@pharmusa.biz
United Kingdom Evidence
24-Jul-19 13:35
95.85.70.225
sgdncw
 
pxfvtf@pharmusa.biz
Russian Federation Evidence
24-Jul-19 12:30
91.222.236.75
cigqxq
 
pkvtfb@pharmusa.biz
Russian Federation Evidence
24-Jul-19 12:02
91.204.14.229
nijavo
 
lzglas@pharmusa.biz
Germany Evidence
24-Jul-19 11:30
5.189.206.223
cnkgmm
 
crftzg@pharmusa.biz
Finland Evidence
24-Jul-19 10:40
91.222.236.102
qazjco
 
iphoen@pharmusa.biz
Russian Federation Evidence
24-Jul-19 10:05
188.68.0.136
zdghqb
 
daesrc@pharmusa.biz
United Kingdom Evidence
24-Jul-19 08:45
95.85.80.208
rqokzc
 
nmmnlq@pharmusa.biz
United Kingdom Evidence
24-Jul-19 06:25
91.222.239.22
emopys
 
fesokb@pharmusa.biz
Russian Federation Evidence
24-Jul-19 05:35
93.179.90.112
fxxzct
 
dkacfc@pharmusa.biz
Czech Republic Evidence
24-Jul-19 04:35
185.251.15.174
duxazq
 
vuwfpg@pharmusa.biz
  Evidence
24-Jul-19 04:15
193.93.195.205
iunwjz
 
gyxror@pharmusa.biz
Russian Federation Evidence
23-Jul-19 20:45
95.85.68.50
dqfgvv
 
ukomoq@pharmusa.biz
Russian Federation Evidence
23-Jul-19 18:30
95.181.176.33
lngiey
 
axdifg@pharmusa.biz
Latvia Evidence
23-Jul-19 17:00
193.32.95.25
rirwbf
 
wifsof@pharmusa.biz
  Evidence
23-Jul-19 10:00
85.202.194.225
agstfx
 
rvfgiq@pharmusa.biz
  Evidence
23-Jul-19 06:55
94.158.22.223
ddweob
 
vrpcip@pharmusa.biz
  Evidence
12-Jul-19 10:00
95.85.69.200
cgcglw
 
yagerh@pharmusa.biz
Russian Federation  
12-Jul-19 10:00
188.68.0.87
cgcglw
 
yagerh@pharmusa.biz
United Kingdom  
12-Jul-19 07:20
91.204.14.204
rpiznm
 
vpncag@pharmusa.biz
Germany Evidence
12-Jul-19 06:44
193.93.192.174
eufcin
 
rsbgsw@pharmusa.biz
United Kingdom  
12-Jul-19 06:44
95.181.176.110
eufcin
 
rsbgsw@pharmusa.biz
Latvia  
12-Jul-19 04:43
5.188.216.198
rqukmh
 
jsiiye@pharmusa.biz
Netherlands Evidence
12-Jul-19 01:56
95.85.80.26
rqfkgo
 
dknmzf@pharmusa.biz
United Kingdom Evidence
12-Jul-19 01:00
83.171.253.52
dexoyf
 
pzvytd@pharmusa.biz
  Evidence
12-Jul-19 00:45
95.85.68.199
ayglhg
 
ghhhzn@pharmusa.biz
Russian Federation Evidence
11-Jul-19 21:58
85.202.194.225
cuwdcj
 
netfrt@pharmusa.biz
   
11-Jul-19 21:58
5.101.220.198
cuwdcj
 
netfrt@pharmusa.biz
Latvia  
11-Jul-19 21:22
5.189.206.174
ubgwqj
 
nawprm@pharmusa.biz
Finland  
11-Jul-19 21:22
185.251.14.30
ubgwqj
 
nawprm@pharmusa.biz
   
11-Jul-19 19:23
2.57.76.248
zjrxvf
 
hakpxa@pharmusa.biz
   
11-Jul-19 19:23
85.202.194.111
zjrxvf
 
hakpxa@pharmusa.biz
   
11-Jul-19 18:50
185.251.14.195
yccrum
 
fxjxlj@pharmusa.biz
   
11-Jul-19 16:05
5.101.220.191
cxhtwh
 
fddtms@pharmusa.biz
Latvia  
11-Jul-19 13:45
91.222.236.117
zjooph
 
bwyato@pharmusa.biz
Russian Federation Evidence
11-Jul-19 12:18
95.181.177.79
ygjfhs
 
vccpuh@pharmusa.biz
Poland  
11-Jul-19 07:55
185.251.70.142
juvfvc
 
fvhpxb@pharmusa.biz
  Evidence
11-Jul-19 00:15
95.181.177.249
xtjajw
 
enmygc@pharmusa.biz
Poland  
11-Jul-19 00:15
95.85.80.141
xtjajw
 
enmygc@pharmusa.biz
United Kingdom  
10-Jul-19 21:20
185.251.15.75
qxyoih
 
qcyfex@pharmusa.biz
  Evidence
10-Jul-19 17:35
46.161.61.138
bxjsat
 
hwygou@pharmusa.biz
Belgium  
10-Jul-19 17:35
95.181.177.105
bxjsat
 
hwygou@pharmusa.biz
Poland  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:21
95.181.218.188
qhjhcc
 
seokmc@pharmusa.biz
Russian Federation  
10-Jul-19 16:21
5.62.154.125
qhjhcc
 
seokmc@pharmusa.biz
Latvia  
10-Jul-19 15:11
185.223.161.29
yppkbk
 
hlbnlr@pharmusa.biz
   
10-Jul-19 10:33
95.85.80.236
envvlk
 
sqqpew@pharmusa.biz
United Kingdom Evidence
10-Jul-19 01:50
95.181.218.196
ppjhfj
 
vaxlex@pharmusa.biz
Russian Federation Evidence
9-Jul-19 23:16
5.101.219.227
enlrdn
 
mkpxqd@pharmusa.biz
Greece  
9-Jul-19 16:44
95.85.69.74
ikoxkd
 
aqwupy@pharmusa.biz
Russian Federation  
9-Jul-19 16:33
95.85.71.70
jkkizs
 
rmljca@pharmusa.biz
Russian Federation  
9-Jul-19 16:28
95.85.80.163
bdlpwa
 
kuldbw@pharmusa.biz
United Kingdom  
9-Jul-19 16:28
5.101.220.183
bdlpwa
 
kuldbw@pharmusa.biz
Latvia  
9-Jul-19 10:30
95.85.80.163
zdjmag
 
xqysig@pharmusa.biz
United Kingdom Evidence
9-Jul-19 06:32
95.181.176.77
ysaedh
 
vtndsf@pharmusa.biz
Latvia  
9-Jul-19 00:35
95.181.218.158
sjugua
 
redqva@pharmusa.biz
Russian Federation Evidence
8-Jul-19 22:18
5.101.219.160
cshykc
 
frdwki@pharmusa.biz
Greece  
8-Jul-19 20:50
2.57.76.159
ucgndv
 
jiweps@pharmusa.biz
  Evidence
8-Jul-19 19:51
5.188.216.201
xbkijr
 
ydspqw@pharmusa.biz
Netherlands  
8-Jul-19 18:25
95.85.80.220
mfhlro
 
vxdiif@pharmusa.biz
United Kingdom Evidence
8-Jul-19 16:15
194.156.125.25
wvvngb
 
yciqpl@pharmusa.biz
   
8-Jul-19 12:58
83.171.252.33
twqabk
 
dyngzo@pharmusa.biz
   
8-Jul-19 11:19
83.171.252.74
xhjths
 
tfmibc@pharmusa.biz
   
8-Jul-19 11:08
95.85.80.198
qcosba
 
gccgkx@pharmusa.biz
United Kingdom  
8-Jul-19 07:51
188.68.0.216
zdrnjd
 
vqwtjg@pharmusa.biz
United Kingdom  
7-Jul-19 22:57
5.188.216.198
cxoagu
 
diyedw@pharmusa.biz
Netherlands  
7-Jul-19 21:32
185.251.15.174
nolhza
 
uyfgtv@pharmusa.biz
   
7-Jul-19 21:32
46.161.60.237
nolhza
 
uyfgtv@pharmusa.biz
Russian Federation  
7-Jul-19 20:29
91.222.239.206
rtldvc
 
vzgfmy@pharmusa.biz
Russian Federation  
7-Jul-19 14:10
185.251.70.247
ckbsjq
 
jojbop@pharmusa.biz
   
7-Jul-19 13:54
5.101.219.136
rmtuhv
 
sqbrlu@pharmusa.biz
Greece  
7-Jul-19 13:53
95.85.68.234
rmtuhv
 
sqbrlu@pharmusa.biz
Russian Federation  
7-Jul-19 13:53
5.189.206.185
rmtuhv
 
sqbrlu@pharmusa.biz
Finland  
7-Jul-19 11:03
193.93.192.170
luvhii
 
zgxvam@pharmusa.biz
United Kingdom  
7-Jul-19 08:06
95.181.218.178
qvymqu
 
bqhnzg@pharmusa.biz
Russian Federation  
7-Jul-19 08:06
93.179.90.58
qvymqu
 
bqhnzg@pharmusa.biz
Czech Republic  
7-Jul-19 06:29
95.85.71.180
iopveb
 
slbpuy@pharmusa.biz
Russian Federation  
4-Jul-19 14:24
188.68.3.218
eyjkbj
 
jzidpd@pharmusa.biz
Czech Republic  
2-Jul-19 21:46
37.9.44.219
ffomsk
 
ndcxivawo@pharmusa.biz
United States  
1-Jul-19 23:40
188.68.3.218
eyjkbj
 
jzidpd@pharmusa.biz
Czech Republic  
1-Jul-19 10:48
194.156.124.216
bbtpde
 
etrrji@pharmusa.biz
   
30-Jun-19 22:42
95.85.69.211
rfamzg
 
gvqhto@pharmusa.biz
Russian Federation  
30-Jun-19 22:05
95.181.218.240
fcuutv
 
vamkdd@pharmusa.biz
Russian Federation Evidence
30-Jun-19 20:25
95.181.176.21
zanpjq
 
bjadpx@pharmusa.biz
Latvia Evidence
30-Jun-19 19:46
176.119.141.137
ontphz
 
mytias@pharmusa.biz
   
30-Jun-19 17:35
5.101.220.165
jbpklm
 
bvlogd@pharmusa.biz
Latvia Evidence
30-Jun-19 15:10
95.85.68.180
sjvxey
 
nxgoel@pharmusa.biz
Russian Federation Evidence
30-Jun-19 15:09
91.222.236.153
noivvf
 
tsqtdl@pharmusa.biz
Russian Federation  
30-Jun-19 12:00
193.93.192.106
mgbiyw
 
ibazqm@pharmusa.biz
United Kingdom Evidence
30-Jun-19 08:37
185.251.70.247
aqchwm
 
dumcyl@pharmusa.biz
   
30-Jun-19 08:09
91.222.239.119
yjoujp
 
cnypmc@pharmusa.biz
Russian Federation  
29-Jun-19 17:20
188.68.3.236
qsuhvs
 
ylebfg@pharmusa.biz
Czech Republic Evidence
29-Jun-19 14:57
95.85.70.225
ebxini
 
awayqt@pharmusa.biz
Russian Federation Evidence
29-Jun-19 11:43
193.93.192.231
ctxkug
 
udsnbi@pharmusa.biz
United Kingdom  
29-Jun-19 09:52
91.222.239.22
szbesw
 
eltoik@pharmusa.biz
Russian Federation  
29-Jun-19 05:55
5.189.206.223
gcnylw
 
igwbbr@pharmusa.biz
Finland Evidence
29-Jun-19 01:55
188.68.3.133
wkugsu
 
kzikos@pharmusa.biz
Czech Republic Evidence
28-Jun-19 22:27
185.223.161.74
zzqqvt
 
tykukm@pharmusa.biz
   
28-Jun-19 14:07
185.223.161.122
zxxdil
 
jtvkop@pharmusa.biz
   
28-Jun-19 13:22
95.181.176.107
acnbsm
 
mcndyc@pharmusa.biz
Latvia  
28-Jun-19 13:22
83.171.252.168
acnbsm
 
mcndyc@pharmusa.biz
   
28-Jun-19 11:05
95.85.69.241
venwds
 
nkwzmw@pharmusa.biz
Russian Federation  
28-Jun-19 10:25
95.85.69.162
yrxwjp
 
okcilx@pharmusa.biz
Russian Federation  
28-Jun-19 10:25
2.57.76.217
yrxwjp
 
okcilx@pharmusa.biz
   
28-Jun-19 09:27
193.32.95.51
ukarxy
 
grnxau@pharmusa.biz
  Evidence
28-Jun-19 08:45
94.158.22.42
opticp
 
tgapgh@pharmusa.biz
  Evidence
28-Jun-19 06:33
185.223.161.212
uhuxjw
 
xbxuva@pharmusa.biz
   
28-Jun-19 05:50
95.85.69.28
kvcsgr
 
jwdtqu@pharmusa.biz
Russian Federation Evidence
28-Jun-19 05:49
185.89.100.137
xhbqbk
 
xqtooz@pharmusa.biz
European Union  
28-Jun-19 04:44
79.110.28.21
Steve Fox
 
puhdjv@pharmusa.biz
United Kingdom  
28-Jun-19 03:17
95.181.176.21
dabkxe
 
nfnkim@pharmusa.biz
Latvia  
28-Jun-19 03:17
37.44.253.57
dabkxe
 
nfnkim@pharmusa.biz
Russian Federation  
28-Jun-19 01:55
95.85.80.141
gboypa
 
ijphcs@pharmusa.biz
United Kingdom Evidence
27-Jun-19 22:53
188.68.3.169
qxttjg
 
ixpahv@pharmusa.biz
Czech Republic  
27-Jun-19 19:36
46.161.60.27
msdpuc
 
ajtbqt@pharmusa.biz
Spain  
27-Jun-19 15:14
188.68.3.236
qqxtri
 
eegodi@pharmusa.biz
Czech Republic  
27-Jun-19 15:11
194.156.125.160
gafdbt
 
axhepe@pharmusa.biz
   
27-Jun-19 14:40
94.158.22.25
qcqdov
 
fqvdat@pharmusa.biz
  Evidence
27-Jun-19 13:13
193.93.192.145
clyfsl
 
qwknrv@pharmusa.biz
United Kingdom  
27-Jun-19 13:06
84.54.58.101
wysjig
 
hunery@pharmusa.biz
   
27-Jun-19 12:43
212.115.51.179
uemqqn
 
soenrs@pharmusa.biz
   
27-Jun-19 12:43
185.251.14.108
uemqqn
 
soenrs@pharmusa.biz
   
27-Jun-19 08:24
188.68.3.68
ofzfvp
 
yrbwwx@pharmusa.biz
Czech Republic  
27-Jun-19 08:24
95.85.71.165
ofzfvp
 
yrbwwx@pharmusa.biz
Russian Federation  
27-Jun-19 07:43
188.68.3.244
vciatp
 
xjfwhi@pharmusa.biz
Czech Republic  
27-Jun-19 06:28
46.161.60.204
snkndr
 
ubmgrm@pharmusa.biz
Russian Federation  
27-Jun-19 06:28
84.54.58.239
snkndr
 
ubmgrm@pharmusa.biz
   
27-Jun-19 04:08
185.251.71.52
nqqaqd
 
elswub@pharmusa.biz
   
27-Jun-19 04:07
185.251.71.52
nqqaqd
 
elswub@pharmusa.biz
   
27-Jun-19 04:07
95.85.70.254
nqqaqd
 
elswub@pharmusa.biz
Russian Federation  
27-Jun-19 02:40
185.251.70.115
lwntxo
 
qurjcd@pharmusa.biz
  Evidence
27-Jun-19 02:38
193.32.95.129
goewkg
 
bvsflc@pharmusa.biz
   
27-Jun-19 02:38
193.32.95.129
goewkg
 
bvsflc@pharmusa.biz
   
27-Jun-19 02:20
185.46.84.130
mhvitk
 
jvbhxm@pharmusa.biz
Poland Evidence
26-Jun-19 21:40
46.161.61.55
owxdfz
 
lbaltv@pharmusa.biz
Iceland  
26-Jun-19 21:37
176.119.141.27
iidmwl
 
hmmxnh@pharmusa.biz
   
26-Jun-19 20:06
194.156.125.154
jfzyok
 
fvkaxu@pharmusa.biz
   
26-Jun-19 16:00
84.54.58.88
ucvpeo
 
rdrsmi@pharmusa.biz
   
22-Jun-19 04:50
95.181.218.15
vqfsmp
 
wtunrnhuc@pharmusa.biz
United States Evidence
22-Jun-19 03:44
5.62.153.79
uoyeib
 
fkzbpftpd@pharmusa.biz
United States  
22-Jun-19 00:39
5.62.156.15
hjfsbg
 
okcylqxtf@pharmusa.biz
United States  
21-Jun-19 23:15
185.46.85.213
crfwms
 
rgssqmzrp@pharmusa.biz
United States Evidence
21-Jun-19 20:03
5.62.153.93
sqkuyz
 
acqzhqarv@pharmusa.biz
United States  
21-Jun-19 18:49
185.14.193.234
bnhalp
 
dstbailbj@pharmusa.biz
Canada  
21-Jun-19 18:49
185.14.193.15
bnhalp
 
dstbailbj@pharmusa.biz
Canada  
21-Jun-19 16:30
95.85.81.153
ibpyqb
 
tnhfmuywi@pharmusa.biz
United States Evidence
21-Jun-19 11:45
185.71.1.179
tkpydt
 
vlwurpwzz@pharmusa.biz
United States  
21-Jun-19 05:48
185.71.2.80
tkmswq
 
hbsuasbyg@pharmusa.biz
United States  
21-Jun-19 02:45
79.110.28.195
cbrgrj
 
mjgbxcryz@pharmusa.biz
United States Evidence
20-Jun-19 22:41
91.204.14.52
ldequk
 
qldkldxyu@pharmusa.biz
United States  
20-Jun-19 22:32
5.62.153.161
xlpofk
 
sweonwyhv@pharmusa.biz
United States  
20-Jun-19 21:20
95.181.218.11
ywpanr
 
sdvvxupng@pharmusa.biz
United States Evidence
20-Jun-19 17:47
95.85.81.108
qlasnf
 
lgirgmhgt@pharmusa.biz
United States  
20-Jun-19 17:01
95.85.81.156
mbcavt
 
scjtgmuhz@pharmusa.biz
United States  
20-Jun-19 17:01
185.71.2.47
mbcavt
 
scjtgmuhz@pharmusa.biz
United States  
20-Jun-19 12:03
5.62.156.114
cggfxk
 
qgqonbocg@pharmusa.biz
United States  
20-Jun-19 06:56
5.189.205.38
msfult
 
mhhadqscq@pharmusa.biz
Canada  
20-Jun-19 06:56
5.62.153.16
msfult
 
mhhadqscq@pharmusa.biz
United States  
18-Jun-19 15:12
185.101.70.201
hcfhyi
 
sfnqmtmoe@pharmusa.biz
United States  
17-Jun-19 06:41
91.200.83.42
zwnxmw
 
phkmvoehu@pharmusa.biz
United States  
12-Jun-19 20:49
5.62.156.201
zysykx
 
gdxooizfi@pharmusa.biz
United States  
12-Jun-19 20:25
5.189.205.31
wvhdkj
 
dditraugb@pharmusa.biz
Canada  
12-Jun-19 20:08
185.71.2.155
gzhnjx
 
sadufrtyz@pharmusa.biz
United States  
12-Jun-19 15:13
5.62.156.233
uwqghd
 
ffmtpgoph@pharmusa.biz
United States  
12-Jun-19 14:27
5.62.153.125
sssapz
 
pajlqgoms@pharmusa.biz
United States  
12-Jun-19 14:24
5.8.44.56
nmsixg
 
xpimysvum@pharmusa.biz
Mexico  
12-Jun-19 13:30
185.71.2.124
mijtkw
 
ajexrvriz@pharmusa.biz
United States Evidence
12-Jun-19 12:57
185.46.85.154
xeatlf
 
kgnnwyxtf@pharmusa.biz
United States  
12-Jun-19 12:42
79.110.31.198
qfffqx
 
uuovdqrmu@pharmusa.biz
Canada  
12-Jun-19 09:28
93.179.89.172
gxccpj
 
nvtabzada@pharmusa.biz
United States  
12-Jun-19 08:48
5.62.156.201
dxrnwq
 
atptsuokt@pharmusa.biz
United States  
12-Jun-19 06:38
185.14.193.103
asybus
 
juokoqgmd@pharmusa.biz
Canada  
12-Jun-19 03:37
185.71.3.110
ynyeab
 
xanxqbmni@pharmusa.biz
United States  
12-Jun-19 00:18
5.8.44.127
qtvmfn
 
inzchhzjg@pharmusa.biz
Mexico  
11-Jun-19 23:57
5.8.44.127
qtvmfn
 
inzchhzjg@pharmusa.biz
Mexico  
11-Jun-19 22:03
5.8.44.127
qtvmfn
 
inzchhzjg@pharmusa.biz
Mexico  
11-Jun-19 21:58
37.9.45.38
bukigt
 
shtygbtnn@pharmusa.biz
United States  
11-Jun-19 21:54
5.189.205.34
kkonbf
 
qbcyynvrw@pharmusa.biz
Canada  
11-Jun-19 20:04
93.179.91.62
ncsawi
 
fzhheucfd@pharmusa.biz
United States  
11-Jun-19 17:44
5.62.153.33
reolhk
 
gsnzjcadv@pharmusa.biz
United States  
11-Jun-19 16:28
37.9.44.17
wtpbnl
 
wwyywdyyi@pharmusa.biz
United States  
11-Jun-19 16:14
5.8.45.54
ddvpet
 
ljolwcmiz@pharmusa.biz
Brazil  
11-Jun-19 14:57
95.85.81.118
nedzyc
 
bggmzzbvf@pharmusa.biz
United States  
11-Jun-19 14:36
79.110.28.207
fhutam
 
quyawjxzx@pharmusa.biz
United States  
11-Jun-19 14:16
5.8.45.234
xdfkiv
 
nmulcvgex@pharmusa.biz
Chile  
11-Jun-19 14:16
95.85.81.146
xdfkiv
 
nmulcvgex@pharmusa.biz
United States  
11-Jun-19 12:54
5.189.207.31
ptzzoj
 
kzustwwjv@pharmusa.biz
United States  
11-Jun-19 12:50
95.85.81.175
hvpoqw
 
jmmdxvliv@pharmusa.biz
United States Evidence
11-Jun-19 11:46
37.9.45.105
goolto
 
zrqavujky@pharmusa.biz
United States  
11-Jun-19 10:41
95.181.218.39
wrbolj
 
iiuuslhod@pharmusa.biz
United States  
11-Jun-19 10:37
5.62.158.86
dmwkah
 
cgorygemh@pharmusa.biz
United States  
11-Jun-19 09:36
91.204.14.57
kolmud
 
merxxzmde@pharmusa.biz
United States  
11-Jun-19 09:00
5.62.158.124
rnerqc
 
eejyryffy@pharmusa.biz
United States  
11-Jun-19 06:53
5.62.156.210
jgaxku
 
hmfpoicdi@pharmusa.biz
United States  
11-Jun-19 06:52
185.71.2.162
jgaxku
 
hmfpoicdi@pharmusa.biz
United States  
11-Jun-19 06:50
37.9.45.34
xknknd
 
kypfmhzfi@pharmusa.biz
United States Evidence
11-Jun-19 06:24
95.85.81.176
hvdrvt
 
xklfbfnae@pharmusa.biz
United States Evidence
11-Jun-19 05:53
5.8.44.115
yuzaro
 
hmcuxloag@pharmusa.biz
Mexico  
11-Jun-19 03:13
185.71.2.65
vzoljb
 
ckwqvlckj@pharmusa.biz
United States Evidence
11-Jun-19 02:02
5.189.206.34
emhtdz
 
bnyrxesrs@pharmusa.biz
United States Evidence
11-Jun-19 02:02
5.189.205.78
xoirds
 
locjljwms@pharmusa.biz
Canada Evidence
11-Jun-19 00:48
95.85.81.37
sicglq
 
vpocrsyis@pharmusa.biz
United States  
11-Jun-19 00:00
5.62.153.84
jzdiwt
 
sntftnsfk@pharmusa.biz
United States  
10-Jun-19 23:46
185.71.2.36
lsjbku
 
ftfiaazwz@pharmusa.biz
United States  
10-Jun-19 23:46
185.71.2.36
lsjbku
 
ftfiaazwz@pharmusa.biz
United States  
10-Jun-19 22:20
93.179.89.181
eeguei
 
sxllkrqtr@pharmusa.biz
United States  
10-Jun-19 19:43
5.8.45.235
yivtgs
 
ezfdxgrfs@pharmusa.biz
Chile  
10-Jun-19 16:54
5.8.44.245
owilgc
 
otjltbhbo@pharmusa.biz
Panama  
10-Jun-19 11:34
5.62.156.84
smxcey
 
iobacywcv@pharmusa.biz
United States  
10-Jun-19 10:28
5.62.156.144
szbyxd
 
vmlyqrblr@pharmusa.biz
United States  
10-Jun-19 09:28
185.101.70.36
iiguja
 
aombchfdm@pharmusa.biz
United States  
9-Jun-19 22:39
5.62.156.234
dvfyif
 
rbagdulvb@pharmusa.biz
United States  
9-Jun-19 21:27
5.8.44.60
ejnsbu
 
ynpsstldz@pharmusa.biz
Mexico  
9-Jun-19 15:35
5.62.153.110
thruto
 
ynxbigomo@pharmusa.biz
United States  
9-Jun-19 15:19
5.62.156.128
ghmvfe
 
joaaeijxk@pharmusa.biz
United States Evidence
9-Jun-19 14:52
5.8.44.188
gqajgr
 
tgytppybl@pharmusa.biz
Panama  
9-Jun-19 14:04
5.62.153.177
klwsrb
 
zoldogjdn@pharmusa.biz
United States  
9-Jun-19 12:18
178.57.66.201
eixtmi
 
mgqtiotxn@pharmusa.biz
United States  
9-Jun-19 11:58
185.101.70.87
tgcgau
 
luifvadut@pharmusa.biz
United States  
9-Jun-19 11:19
185.71.0.219
qqfczy
 
uimuwqmxw@pharmusa.biz
United States  
9-Jun-19 10:22
5.62.158.69
bmecmh
 
czjyopdus@pharmusa.biz
United States  
9-Jun-19 10:17
185.71.2.28
abrvmo
 
owrulpzur@pharmusa.biz
United States  
9-Jun-19 09:46
185.46.85.223
sfxpot
 
hyaubatqy@pharmusa.biz
United States  
9-Jun-19 08:04
185.46.85.173
pkmegr
 
moonxcuuf@pharmusa.biz
United States  
9-Jun-19 07:32
95.85.81.20
gvkrhs
 
zbdfwzhpq@pharmusa.biz
United States  
9-Jun-19 07:09
5.62.156.111
dfigfh
 
ylckblasd@pharmusa.biz
United States Evidence
9-Jun-19 06:15
185.71.2.68
yubzet
 
vowgbvotl@pharmusa.biz
United States  
9-Jun-19 05:34
5.8.45.39
ztnkav
 
gknfirxrf@pharmusa.biz
Brazil  
9-Jun-19 05:34
5.62.156.48
ztnkav
 
gknfirxrf@pharmusa.biz
United States  
9-Jun-19 05:30
5.8.45.39
ckjway
 
thxjhqbqz@pharmusa.biz
Brazil Evidence
9-Jun-19 05:01
91.200.83.88
hsfjya
 
wfiaekpcz@pharmusa.biz
United States Evidence
8-Jun-19 21:11
5.189.205.120
shopax
 
pcfqlujjt@pharmusa.biz
Canada  
8-Jun-19 19:51
79.110.31.195
oxtkqq
 
mhrumuipt@pharmusa.biz
Canada  
8-Jun-19 19:40
185.71.1.227
pbspxk
 
rwzmgflzc@pharmusa.biz
United States  
8-Jun-19 17:49
5.8.45.67
zuxthu
 
jjitdwjwf@pharmusa.biz
Brazil  
8-Jun-19 16:35
5.62.156.144
acwtpn
 
opvnuemiq@pharmusa.biz
United States  
8-Jun-19 12:13
5.8.45.83
ckzqwo
 
otlglypub@pharmusa.biz
Brazil  
8-Jun-19 10:58
95.85.81.176
zhiwzn
 
iycrciedz@pharmusa.biz
United States  
Legend
toxic Toxic IP address or "bad" email domain
tor TOR exit node
Highlighted Hot IP or disposable email address

Abuse History for domain pharmusa.biz

Close
Close